SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-000350
Filing Date
2022-01-19
Accepted
2022-01-19 15:15:05
Documents
2
Period of Report
2022-01-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K insd_8k.htm 8-K 18258
2 PRESS RELEASE insd_ex991.htm EX-99.1 9627
  Complete submission text file 0001477932-22-000350.txt   29218
Mailing Address 1545 CROSSWAYS BLVD. SUITE 250 CHESAPEAKE VA 23320-0218
Business Address 1545 CROSSWAYS BLVD. SUITE 250 CHESAPEAKE VA 23320-0218 800-542-8715
Instadose Pharma Corp. (Filer) CIK: 0001697587 (see all company filings)

IRS No.: 813599639 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 333-216292 | Film No.: 22538421
SIC: 2510 Household Furniture